Trials / Conditions / L2 Childhood Acute Lymphoblastic Leukemia
L2 Childhood Acute Lymphoblastic Leukemia
4 registered clinical trials studyying L2 Childhood Acute Lymphoblastic Leukemia.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patient NCT00382109 | Children's Oncology Group | Phase 3 |
| Completed | Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell NCT00381680 | Children's Oncology Group | Phase 3 |
| Completed | Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia NCT00061945 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia NCT00049569 | National Cancer Institute (NCI) | N/A |